Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol Addition for Hemorrhagic Stroke
NCT03743103Phase 4Terminated
- Sponsor
- Cristália
- Start
- Apr 2019
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of esmolol in hemorrhagic stroke, sponsored by Cristália. Started Apr 2019; status: terminated.
02
Drugs
esmolol
03
Conditions
hemorrhagic stroke
Beyond the preview
Go deeper on NCT03743103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03743103.